Irving, TX (PRWEB) June 20, 2012
The growing aging population and increasing health consciousness among the global populace is likely to drive the global retail drug industry, and the market is forecast to reach an estimated US $1,420 billion in 2017 with a CAGR of 3.6% over the next five years.
Lucintel, a leading global management consulting and market research firm, has analyzed the Global Drug Retail market and presents its findings in “Global Retail Drug Industry 2012-2017: Trend, Profit, and Forecast Analysis.”
The retail drug industry consists of pharmacies and drug stores engaged in retailing prescription or nonprescription drugs and medicines, cosmetics, beauty supplies, perfume, optical goods, and health and personal care stores. The industry is highly fragmented and dependent upon macroeconomic factors such as GDP, disposable income, and consumer spending.
The global retail drug market holds immense potential because most of the countries are still under-penetrated. Drug stores are poised for significant growth, as the average age of the consumer is increasing rapidly. An aging population needs increased health care and prescription needs, thus providing a growing customer base for drug stores.
APAC depicts the best growth prospects for retailers in forth coming years with increasing aging population, health consciousness, and consumer demand. Increasing industry share of Asian economies in world trade and rapid industrialization in emerging economies are expected to boost demand in this region. Thus, APAC is expected to grow at a faster pace than other regions.
This study provides an overview of the global retail drug industry. The report tracks market sizing for four geographic regions of the global retail drug industry. For a detailed table of contents and pricing information on these timely, insightful reports, contact Lucintel at +1-972-636-5056 or via email at helpdesk(at)lucintel(dot)com. Lucintel provides cutting-edge decision support services that facilitate critical decisions with greater speed, insight, and cost efficiency.